FDA Panel Endorses ESA for Patients on Dialysis - MedPage Today PDF Print
MedPage Today
The Oncologic Drugs Advisory Committee concluded that peginesatide, made by Affymax, appears to work as well as currently-available ESAs to raise hemoglobin levels and reduce the need for red blood cell transfusions in patients on dialysis. ...
FDA panel gives nod to Affymax drug for anemia Reuters
FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.